<DOC>
	<DOCNO>NCT00980135</DOCNO>
	<brief_summary>The study shall prove whether treatment atopic dermatitis equally effective Sinecort cream compare standard therapy ( Hydrocortisone cream ) .</brief_summary>
	<brief_title>Sinecort Pilot Efficacy Study</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Male female Caucasians age 18 65 year Patients mild AD present score AD ( SCORAD ) rating 325 Skin type I IV accord Fitzpatrick Acute AD symptom assessment area ( local SCORAD &gt; /=3 &lt; = 12 ) Acute symptom pruritus Baseline Any skin disease test area would interfere clinical assessment opinion investigator Moles , tattoo , strong pigmentation , scar test area would interfere clinical assessment Regular intake antiphlogistic drug ( example , NSAIDs ) Any condition treatment might influence trial ( e.g . treatment topical antibiotic , antifungal , corticoid ) within 14 day prior screen well trial ( exception : topical treatment AD lesion test area ( example , face ) low potency steroid restrict small area ) UVtherapy use solarium within 30 day screen well trial Any alternative treatment AD ( e.g . acupuncture , kinesiology , homoeopathy ) within 30 day screen well trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Sinecort</keyword>
	<keyword>Hydrocortison</keyword>
	<keyword>Mild atopic dermatitis</keyword>
	<keyword>Efficacy , safety</keyword>
</DOC>